High-Content Imaging of Live Cells to Differentiate Drug Treatments
Join our webinar to discover how non-toxic 3D cell painting and advanced high-content imaging are transforming drug profiling and disease phenotyping. Learn why traditional imaging methods (e.g., widefield, point scan) fall short due to slow speeds, phototoxicity, and poor image quality, and discover cutting-edge solutions that overcome these challenges.
Key Topics
-
Enhanced Drug Profiling: Discover how non-toxic 3D live-cell painting improves profiling of drug candidates, disease phenotypes, and genetic perturbations.
-
Superior 3D Models: Understand why 3D live-cell models better replicate in vivo conditions, revealing unique drug responses compared to 2D models.
-
Practical Strategies: Gain actionable insights to implement these innovations for faster, more accurate results in your research.
Featured Speakers:
![]() |
Martin Cottet, PhD |
![]() |
Dan Collins |
Related Industries
-
Pharmaceutical
Under continual pressure to increase profitability, maintain government compliance, and meet emerging market opportunities, the pharmaceutical manufacturing industry faces unique challenges that require unique solutions. As one of the world’s leading industrial automation suppliers, Yokogawa is poised and prepared to deliver those solutions, creating individualized lean manufacturing techniques that deliver consistent, measurable results.
Related Products & Solutions
-
Benchtop CQ1 Confocal System
Optimize lab space while driving fast, accurate results.
-
High-Content Analysis Software
Intuitive software solutions for advanced results.
-
High-Content Analysis Systems
Utilizing powerful software, high-content analysis (HCA) systems address a wide range of research applications from basic science to complex compound screening.
-
Life Science
Yokogawa’s sensitivity and precision solutions enable rapid and accurate measurements, empowering groundbreaking research, accelerating drug discovery, and optimizing bio-production at scale.